Manufacturing plant and offices set up for HDR brachytherapy devices in China

2019-08-01 Page Views : 916 Author : Admin

Important Notes:

In January 2021, BEBIG Medical GmbH took over the global production and distribution structures of the HDR brachytherapy products of Eckert & Ziegler BEBIG GmbH including Mick Radio-Nuclear Instruments, Inc.

Below news are related to the HDR brachytherapy business and is quoted originally from the website:


Original Content:

Eckert & Ziegler AG (ISIN DE0005659700), a global radioisotope specialist headquartered in Berlin, Germany, has formed a joint venture with Chinese TCL Healthcare Equipment (Shanghai) Co., Ltd. (TCL Healthcare) for the development, production and distribution of advanced tumor irradiation devices highly effective against gynecological and other forms of cancer. The joint venture will trade under TCL Eckert & Ziegler BEBIG Healthcare (Wuxi) Co. Ltd. and is held 49% by EZAG and 51% by TCL. TCL Healthcare belongs to Chinese electronics group TCL Corporation with more than 16 billion USD revenues.

"We look forward to advancing brachytherapy with a strong partner in China. The tumor irradiation device produced in China and for the Chinese market opens up completely new market opportunities for us. Every year, around 4 million people in China get cancer (source: WHO). With the joint venture, we have reached another important milestone in our global growth strategy”, explained Dr. Harald Hasselmann, member of the Executive Board of Eckert & Ziegler AG and Managing Director of Eckert & Ziegler BEBIG GmbH.

“Medical devices from Germany have a high standing in China. The cooperation with Eckert & Ziegler BEBIG offers us a unique opportunity to contribute our experience in development, production, approval and sales and to further develop brachytherapy for the benefit of the patients. The core competencies of both partners will complement each other perfectly in the rapidly growing Chinese healthcare market”, said George Chan, Managing Director of TCL Healthcare Equipment (Shanghai) Co., Ltd.


About BEBIG Medical GmbH:

BEBIG Medical GmbH (“BEBIG Medical”) is a global provider of high quality radiation therapy products for cancer treatment headquartered in Berlin, Germany. Preceded by the high dose brachytherapy business unit of Eckert & Ziegler AG, BEBIG Medical has a heritage of more than 40 years’ experience in brachytherapy field and continues to provide affordable healthcare with proven clinical outcomes via strong and viable technology.BEBIG Medical’s US subsidiary, Mick Radio-Nuclear Instruments, Inc., is also known internationally for its manufacturing expertise in the field of applicators and accessories to advance brachytherapy. With a team of professionals and offices in Europe, United States and Asia, the company is empowered to serve customers in more than 65 countries and regions together with a worldwide distribution network.



Crystal Chen, Chief Commercial Officer:

Related News
+49 30 9487888-10
Robert-Rössle-Str. 10, 13125 Berlin Germany

Copyright © BEBIG Medical. All rights reserved.